TRANSFORM3 is a quality improvement effort that evaluates strategies to improve use of guideline-directed therapeutics known to lower cardiovascular (CV) events among patients with CV diseases of heart failure, atrial fibrillation and type 2 diabetes with a specific focus on underserved populations and those with a history of health care disparities. The strategies evaluated include: technology-based decision support, referral to a virtual GDMT team and general educational tools and resources for clinicians and patients.

Please review the resources below.

Resources

• IRB Protocol
  
  

  Patients Randomized – 3 Quality Improvement Arms
  Arm	Duration	Surveys	Primary Outcome	Secondary Outcome
  Teaching - CardioSmart Resources + Clinician Education	9 months	Patient perception QOL	GDMT baseline to 9 month change in average composite endpoint of receiving the main classes of drugs (50% or higher of target doses for HF) among eligible patients	QOL Individual drug improvements Patient perception Cost/cost effectiveness
  Technology - Facilitated Solution (Existing Team)
  Teams - Protocol-Supported Team, (Virtual GDMT Team)

• Patient Resources
• Biofourmis Technical Resources
  • Patient App
    • Download the App (pdf)
    • Quickstart Guide (pdf)
    • Settings (pdf)
    • Complete a Task (pdf)
    • Vital Signs (pdf)
    • Medications (pdf)
    • Contact a Study Coordinator (pdf)
  • Study Coordinator and Clinician User Guides
    • Patient Onboarding – Veradigm (pdf)
    • Patient Onboarding – Non-Veradigm (pdf)
    • Navigating the Home Screen (pdf)
    • Patient Management (pdf)
    • Medications (Web Dashboard) (pdf)
    • Patient Offboarding (pdf)
  • TEAM Arm Resources
    • Weekly Communication Log
    • Data Validation Checklist
  • Biofourmis Technical Support Number: 1-855-433-1678